Viewing Study NCT06465732


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2025-12-31 @ 3:55 AM
Study NCT ID: NCT06465732
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-20
First Post: 2024-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module